spacer
home > pmps > summer 2019 > redefining supply
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Redefining Supply

Passive packaging is coming of age. In a world where door-to-door delivery is transforming the consumer experience, more and more sectors are waking up to the possibilities of delivering temperature-controlled products in a simple, cost-effective, and reliable way.

As the world faces the challenges of global warming, new approaches to packaging also provide opportunities to reassess the impact of supply chains on the planet. However, while industries such as retail and food have been quick to adopt new forms of delivery, they do so without the strict regulations and restraints that often apply to the pharmaceutical sector.

As Managing Director of a company that has invested millions in R&D for passive packaging solutions, I am well aware of both the challenges and benefits they can bring to pharma customers, and, as a passionate believer in the properties of natural materials, I appreciate the particular challenges a more ecological packaging approach presents to this most scientific of sectors.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Josie Morris BA (Hons), MA, is Managing Director at The Wool Packaging Company Ltd (Woolcool). A passionate advocate for diversity and the development of strong cultures within innovative businesses, Josie is also closely involved with organisations such as the Bio-Based Industries Association (BBIA), which lobby the UK government on the environmental problems of global packaging waste and support pioneering companies such as Woolcool that offer genuinely sustainable alternatives to plastic materials.
spacer
josie@woolcool.com
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Protagen Protein Services Merges with GeneWerk to Integrate Leading Protein and Gene Therapy Analytic Platforms

Heilbronn/Boston July 1st 2021: Protagen Protein Services (PPS) today announced that it will merge with GeneWerk, an Ampersand portfolio company.
More info >>

White Papers

Keeping Abreast of the Competitive Environment in Clinical Development

Thomson Reuters

Strategic management of a therapy area requires hard decisions to be made about which programs to invest in and which to let go. Understanding the rapidly changing competitive environment for your drug candidates is a key input into these decisions. It is easy to lose track of the broader picture when a clinical program is in progress and get blindsided by external events.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement